Product
PPI Control
1 clinical trial
1 indication
Indication
Erosive EsophagitisClinical trial
A Phase 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisStatus: Recruiting, Estimated PCD: 2024-06-30